ACS Medicinal Chemistry Letters · 2016 · 38 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryBreast Cancer PharmacotherapyGonadal HormonesGonadal Steroid HormonesHormonal Cancer TherapyHormonal TherapyHormone ReceptorsBreast Cancer Endocrine TherapyBreast Cancer Hormonal TherapyBreast Cancer Hormone TherapyEstrogen PharmacologyEstrogen ReceptorsFluorescence Resonance Energy TransferHormone Receptor ModulationRational Design
Development of orally bioavailable nonsteroidal selective estrogen receptor downregulators (SERDs) provides clinical opportunities for the long-term treatment and adjuvant therapy of breast cancer at all stages. We describe the design, synthesis, and identification of a boron-modified GW7604 derivative (GLL398, 9 ), a SERD candidate, in which a boronic acid functional group replaces the phenolic hydroxyl group of GW7604. Compound 9 strongly binds to ERα in a fluorescence resonance energy transfer binding assay (IC 50 = 1.14 nM) and potently degrades ERα in MCF-7 breast cancer cells (IC 50 = 0.21 μM). Most importantly, the introduction of the boronic acid group confers superior oral bioavailability of 9 (AUC = 36.9 μg·h/mL) in rats as compared to GW7604 (AUC = 3.35 μg·h/mL). The strikingly favorable pharmacokinetic property of 9 makes it a promising oral SERD suitable for clinical evaluation.
20
Andiliy Lai, Mehmet Kahraman, Steven P. Govek et al. · Journal of Medicinal Chemistry · 2015 · 247 citations · Full text
Medicine, Oncology, Pharmacology +13
Comparative Analyses of Mechanistic Differences Among Antiestrogens1
Ashini L. Wijayaratne, Susan C. Nagel, Lisa A. Paige et al. · Endocrinology · 1999 · 245 citations · Full text
Medicine, Oncology, Pharmacology +16
Structural Basis for an Unexpected Mode of SERM-Mediated ER Antagonism
Ya-Ling Wu, Xiaojing Yang, Zhong Ren et al. · Molecular Cell · 2005 · 238 citations · Full text
Chris De Savi, Robert H. Bradbury, Alfred A. Rabow et al. · Journal of Medicinal Chemistry · 2015 · 160 citations · Full text